江苏吴中医药集团有限公司咋样
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., also known as Jiangsu Wuzhong Pharmaceutical Suzhou Factory, is a leading pharmaceutical company in Jiangsu Province, China. The company specializes in the research, development, and production of a wide range of pharmaceutical products.
1. Pharmaceutical Products for Bronchitis
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. offers a variety of medicines suitable for treating bronchitis. One of its notable products is Cefpirome Sulfate, which effectively treats respiratory tract infections caused by sensitive bacteria. This medication is available in various dosages and is known for its effectiveness in relieving bronchitis symptoms.
2. Production of Cardiac Medication
The company is involved in the production of cardiovascular medications, including the renowned Carvedilol tablets. Carvedilol is commonly used for the treatment of heart failure and high blood pressure. It exerts its effects by blocking certain receptors in the heart and blood vessels, thereby reducing the workload on the heart and improving overall cardiac function.
3. Real Estate Ventures
In 2010, Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. expanded its business by establishing Jiangsu Wuzhong Real Estate Co., Ltd. However, due to strict regulations and limitations in the real estate industry, the company faced a significant decline in revenue from this sector. Despite challenges, the company has managed to maintain a steady growth trajectory in its pharmaceutical ventures.
4. Employment and Work Culture
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. is known to provide stable employment opportunities, particularly for individuals seeking a calmer work environment. The company offers competitive salaries and benefits. However, career advancement within the organization may be limited, and turnover of younger employees is relatively high.
5. New Drug Approvals
In recent news, Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. received approval from the National Medical Products Administration for the production of "Levocetirizine Hydrochloride Sustained-Release Tablets." This new medication is utilized for the treatment of allergic rhinitis and chronic idiopathic urticaria. Its approval showcases the company's dedication to innovation and expanding its product portfolio.
6. Chinese Patent Medicine
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. has developed and produces the proprietary product "Lianqin Pearl Pills." This Chinese patent medicine is primarily used for the treatment of recurrent aphthous stomatitis, also known as canker sores. The pills exhibit properties of clearing heat, detoxifying the body, and providing pain relief, making it a popular choice among patients suffering from this condition.
7. Short-Acting Leukocyte Growth Factors
The company also manufactures short-acting leukocyte growth factors, such as recombinant human granulocyte colony-stimulating factor (rhG-CSF). These factors are primarily used to treat neutropenia, a condition characterized by a decrease in neutrophils, a type of white blood cell. Neutropenia commonly occurs in cancer patients undergoing chemotherapy.
8. Biopharmaceutical Research and Development
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. is a core subsidiary of Jiangsu Wuzhong Industrial Co., Ltd. and serves as a leading enterprise in the national Torch Program Wuzhong Pharmaceutical Industry Base. The company is engaged in the research and development of biopharmaceuticals, chemical drugs, and modern Chinese medicines. It continually strives to innovate and enhance its product offerings to meet the evolving healthcare needs of the population.
Conclusion
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd., also known as Jiangsu Wuzhong Pharmaceutical Suzhou Factory, is a renowned pharmaceutical company based in Jiangsu Province, China. With a diverse product portfolio, the company focuses on the development of medicines for various conditions, including bronchitis, cardiovascular diseases, and allergic disorders. While the real estate ventures faced challenges, the pharmaceutical segment continues to thrive. Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. is dedicated to innovation and ensuring the availability of effective and high-quality drugs to meet the healthcare needs of the population.